{
  "name": "Related EU Clinical Trial Programs and Regulations",
  "description": "This table compares key regulatory frameworks and guidelines governing clinical trials and Investigational Medicinal Products (IMPs) in the European Union, compiled from EU legal documents.",
  "page": "https://casrai.org/guides/annex-13",
  "publisher": "CASRAI",
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "dateModified": "2026-11-17T04:39:54Z",
  "temporalCoverage": null,
  "spatialCoverage": null,
  "columns": [
    {
      "name": "Program/Regulation",
      "unit": "",
      "description": "Name of the program or regulation"
    },
    {
      "name": "Description",
      "unit": "",
      "description": "A brief overview of the program or regulation"
    },
    {
      "name": "Relationship to IMPs",
      "unit": "",
      "description": "How it impacts IMPs"
    }
  ],
  "rows": [
    {
      "Program/Regulation": "Regulation (EU) 536/2014 (CTR)",
      "Description": "Clinical Trials Regulation",
      "Relationship to IMPs": "Replaces Annex 13 and governs trial conduct and IMP requirements."
    },
    {
      "Program/Regulation": "EudraLex Volume 4",
      "Description": "GMP Guidelines",
      "Relationship to IMPs": "Provides detailed guidance for GMP compliance in the EU."
    },
    {
      "Program/Regulation": "Good Clinical Practice (GCP)",
      "Description": "Standards for trial conduct",
      "Relationship to IMPs": "Ensures the rights, safety, and well-being of trial subjects are protected."
    }
  ],
  "sources": [
    {
      "title": "Regulation (EU) No 536/2014",
      "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32014R0536",
      "accessed": "2026-11-17"
    },
    {
      "title": "EudraLex Volume 4",
      "url": "https://health.ec.europa.eu/medicinal-products/eudralex/eudralex-volume-4_en",
      "accessed": "2026-11-17"
    }
  ]
}